Global Parkinson's Disease Market Research Report 2023

The global Parkinson's Disease market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Parkinson's Disease in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Parkinson's Disease include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease.

The Parkinson's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Parkinson's Disease market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Carbidopa/Levodopa

1.2.3 Dopamine Receptor Agonists

1.2.4 MAO-Inhibitors

1.3 Market by Application

1.3.1 Global Parkinson's Disease Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Parkinson's Disease Market Perspective (2018-2029)

2.2 Parkinson's Disease Growth Trends by Region

2.2.1 Global Parkinson's Disease Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Parkinson's Disease Historic Market Size by Region (2018-2023)

2.2.3 Parkinson's Disease Forecasted Market Size by Region (2024-2029)

2.3 Parkinson's Disease Market Dynamics

2.3.1 Parkinson's Disease Industry Trends

2.3.2 Parkinson's Disease Market Drivers

2.3.3 Parkinson's Disease Market Challenges

2.3.4 Parkinson's Disease Market Restraints

3.1 Global Top Parkinson's Disease Players by Revenue

3.1.1 Global Top Parkinson's Disease Players by Revenue (2018-2023)

3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2018-2023)

3.2 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Parkinson's Disease Revenue

3.4 Global Parkinson's Disease Market Concentration Ratio

3.4.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2022

3.5 Parkinson's Disease Key Players Head office and Area Served

3.6 Key Players Parkinson's Disease Product Solution and Service

3.7 Date of Enter into Parkinson's Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Parkinson's Disease Historic Market Size by Type (2018-2023)

4.2 Global Parkinson's Disease Forecasted Market Size by Type (2024-2029)

5.1 Global Parkinson's Disease Historic Market Size by Application (2018-2023)

5.2 Global Parkinson's Disease Forecasted Market Size by Application (2024-2029)

6.1 North America Parkinson's Disease Market Size (2018-2029)

6.2 North America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Parkinson's Disease Market Size by Country (2018-2023)

6.4 North America Parkinson's Disease Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Parkinson's Disease Market Size (2018-2029)

7.2 Europe Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Parkinson's Disease Market Size by Country (2018-2023)

7.4 Europe Parkinson's Disease Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Parkinson's Disease Market Size (2018-2029)

8.2 Asia-Pacific Parkinson's Disease Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023)

8.4 Asia-Pacific Parkinson's Disease Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Parkinson's Disease Market Size (2018-2029)

9.2 Latin America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Parkinson's Disease Market Size by Country (2018-2023)

9.4 Latin America Parkinson's Disease Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Parkinson's Disease Market Size (2018-2029)

10.2 Middle East & Africa Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023)

10.4 Middle East & Africa Parkinson's Disease Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Teva

11.1.1 Teva Company Detail

11.1.2 Teva Business Overview

11.1.3 Teva Parkinson's Disease Introduction

11.1.4 Teva Revenue in Parkinson's Disease Business (2018-2023)

11.1.5 Teva Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Parkinson's Disease Introduction

11.2.4 Novartis Revenue in Parkinson's Disease Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 GSK

11.3.1 GSK Company Detail

11.3.2 GSK Business Overview

11.3.3 GSK Parkinson's Disease Introduction

11.3.4 GSK Revenue in Parkinson's Disease Business (2018-2023)

11.3.5 GSK Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Detail

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Parkinson's Disease Introduction

11.4.4 AbbVie Revenue in Parkinson's Disease Business (2018-2023)

11.4.5 AbbVie Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Parkinson's Disease Introduction

11.5.4 Merck Revenue in Parkinson's Disease Business (2018-2023)

11.5.5 Merck Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Detail

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Parkinson's Disease Introduction

11.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023)

11.6.5 Boehringer Ingelheim Recent Development

11.7 Amneal + Impax

11.7.1 Amneal + Impax Company Detail

11.7.2 Amneal + Impax Business Overview

11.7.3 Amneal + Impax Parkinson's Disease Introduction

11.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023)

11.7.5 Amneal + Impax Recent Development

11.8 Lundbeck

11.8.1 Lundbeck Company Detail

11.8.2 Lundbeck Business Overview

11.8.3 Lundbeck Parkinson's Disease Introduction

11.8.4 Lundbeck Revenue in Parkinson's Disease Business (2018-2023)

11.8.5 Lundbeck Recent Development

11.9 Sun Pharma

11.9.1 Sun Pharma Company Detail

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Parkinson's Disease Introduction

11.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2018-2023)

11.9.5 Sun Pharma Recent Development

11.10 Wockhardt

11.10.1 Wockhardt Company Detail

11.10.2 Wockhardt Business Overview

11.10.3 Wockhardt Parkinson's Disease Introduction

11.10.4 Wockhardt Revenue in Parkinson's Disease Business (2018-2023)

11.10.5 Wockhardt Recent Development

11.11 UCB

11.11.1 UCB Company Detail

11.11.2 UCB Business Overview

11.11.3 UCB Parkinson's Disease Introduction

11.11.4 UCB Revenue in Parkinson's Disease Business (2018-2023)

11.11.5 UCB Recent Development

11.12 Bausch Health

11.12.1 Bausch Health Company Detail

11.12.2 Bausch Health Business Overview

11.12.3 Bausch Health Parkinson's Disease Introduction

11.12.4 Bausch Health Revenue in Parkinson's Disease Business (2018-2023)

11.12.5 Bausch Health Recent Development

11.13 Acadia

11.13.1 Acadia Company Detail

11.13.2 Acadia Business Overview

11.13.3 Acadia Parkinson's Disease Introduction

11.13.4 Acadia Revenue in Parkinson's Disease Business (2018-2023)

11.13.5 Acadia Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Carbidopa/Levodopa

    Table 3. Key Players of Dopamine Receptor Agonists

    Table 4. Key Players of MAO-Inhibitors

    Table 5. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Parkinson's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Parkinson's Disease Market Share by Region (2018-2023)

    Table 9. Global Parkinson's Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Parkinson's Disease Market Share by Region (2024-2029)

    Table 11. Parkinson's Disease Market Trends

    Table 12. Parkinson's Disease Market Drivers

    Table 13. Parkinson's Disease Market Challenges

    Table 14. Parkinson's Disease Market Restraints

    Table 15. Global Parkinson's Disease Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Parkinson's Disease Market Share by Players (2018-2023)

    Table 17. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)

    Table 18. Ranking of Global Top Parkinson's Disease Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Parkinson's Disease Product Solution and Service

    Table 22. Date of Enter into Parkinson's Disease Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Parkinson's Disease Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Parkinson's Disease Revenue Market Share by Type (2018-2023)

    Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Parkinson's Disease Revenue Market Share by Type (2024-2029)

    Table 28. Global Parkinson's Disease Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Parkinson's Disease Revenue Market Share by Application (2018-2023)

    Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Parkinson's Disease Revenue Market Share by Application (2024-2029)

    Table 32. North America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Parkinson's Disease Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Teva Company Detail

    Table 48. Teva Business Overview

    Table 49. Teva Parkinson's Disease Product

    Table 50. Teva Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 51. Teva Recent Development

    Table 52. Novartis Company Detail

    Table 53. Novartis Business Overview

    Table 54. Novartis Parkinson's Disease Product

    Table 55. Novartis Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 56. Novartis Recent Development

    Table 57. GSK Company Detail

    Table 58. GSK Business Overview

    Table 59. GSK Parkinson's Disease Product

    Table 60. GSK Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 61. GSK Recent Development

    Table 62. AbbVie Company Detail

    Table 63. AbbVie Business Overview

    Table 64. AbbVie Parkinson's Disease Product

    Table 65. AbbVie Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 66. AbbVie Recent Development

    Table 67. Merck Company Detail

    Table 68. Merck Business Overview

    Table 69. Merck Parkinson's Disease Product

    Table 70. Merck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 71. Merck Recent Development

    Table 72. Boehringer Ingelheim Company Detail

    Table 73. Boehringer Ingelheim Business Overview

    Table 74. Boehringer Ingelheim Parkinson's Disease Product

    Table 75. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 76. Boehringer Ingelheim Recent Development

    Table 77. Amneal + Impax Company Detail

    Table 78. Amneal + Impax Business Overview

    Table 79. Amneal + Impax Parkinson's Disease Product

    Table 80. Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 81. Amneal + Impax Recent Development

    Table 82. Lundbeck Company Detail

    Table 83. Lundbeck Business Overview

    Table 84. Lundbeck Parkinson's Disease Product

    Table 85. Lundbeck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 86. Lundbeck Recent Development

    Table 87. Sun Pharma Company Detail

    Table 88. Sun Pharma Business Overview

    Table 89. Sun Pharma Parkinson's Disease Product

    Table 90. Sun Pharma Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 91. Sun Pharma Recent Development

    Table 92. Wockhardt Company Detail

    Table 93. Wockhardt Business Overview

    Table 94. Wockhardt Parkinson's Disease Product

    Table 95. Wockhardt Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 96. Wockhardt Recent Development

    Table 97. UCB Company Detail

    Table 98. UCB Business Overview

    Table 99. UCB Parkinson's Disease Product

    Table 100. UCB Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 101. UCB Recent Development

    Table 102. Bausch Health Company Detail

    Table 103. Bausch Health Business Overview

    Table 104. Bausch Health Parkinson's Disease Product

    Table 105. Bausch Health Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 106. Bausch Health Recent Development

    Table 107. Acadia Company Detail

    Table 108. Acadia Business Overview

    Table 109. Acadia Parkinson's Disease Product

    Table 110. Acadia Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)

    Table 111. Acadia Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Parkinson's Disease Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Parkinson's Disease Market Share by Type: 2022 VS 2029

    Figure 3. Carbidopa/Levodopa Features

    Figure 4. Dopamine Receptor Agonists Features

    Figure 5. MAO-Inhibitors Features

    Figure 6. Global Parkinson's Disease Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Parkinson's Disease Market Share by Application: 2022 VS 2029

    Figure 8. Hospitals Case Studies

    Figure 9. Clinics Case Studies

    Figure 10. Parkinson's Disease Report Years Considered

    Figure 11. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Parkinson's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Parkinson's Disease Market Share by Region: 2022 VS 2029

    Figure 14. Global Parkinson's Disease Market Share by Players in 2022

    Figure 15. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2022

    Figure 17. North America Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Parkinson's Disease Market Share by Country (2018-2029)

    Figure 19. United States Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Parkinson's Disease Market Share by Country (2018-2029)

    Figure 23. Germany Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Parkinson's Disease Market Share by Region (2018-2029)

    Figure 31. China Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Parkinson's Disease Market Share by Country (2018-2029)

    Figure 39. Mexico Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Parkinson's Disease Market Share by Country (2018-2029)

    Figure 43. Turkey Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Teva Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 46. Novartis Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 47. GSK Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 48. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 49. Merck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 50. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 51. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 52. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 53. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 54. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 55. UCB Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 56. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 57. Acadia Revenue Growth Rate in Parkinson's Disease Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed